Eisai Boards Fast Boat To China In HER2-Targeting ADC Deal With Bliss

 
• By Alaric DeArment
  
Eisai announced a deal with BlissBio for the Chinese company's HER2-directed ADC • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business